Spatial expression pattern of DAg1 in Danio rerio embryos as revealed by in situ hybridization.

Scientific projects of postgraduate students of IBCh have become the winners of the program of Skolkovo Institute of Science and Technology to support young scientists in systems biology. The researchers will receive scholarship money to study two issues: responses of T-cell immunity to a live vaccine against yellow fever in genetically identical twins, as well as search and analysis of genetic target gene, which is responsible for brain development and regeneration of the body appendages in vertebrates.


  • Russian Scientists have detected unusual behavior of the PIWIL2 gene “helpers” science news VII.15

    A team of scientists from the Institute of Bioorganic Chemistry RAS have discovered new information on how the PIWIL2 human gene expresses itself. This breakthrough discovery shall help create a diagnostic marker for determining testicular germ cell tumors. The research findings suggest the interchangeability of the PIWIL2 “helpers”: the promoter of this gene is also able to act as an enhancer of the expression of another gene. The work, published in the PLoS ONE journal, helps expand the background knowledge in this field.

  • How research into glowing fungi could lead to trees lighting our streets (The Guardian) science news VII.8

    On a moonless night deep in a Brazilian rainforest the only thing you are likely to see are the tiny smears of light from flitting fireflies or the ghostly glow of mushrooms scattered around the forest floor. Both effects are the result of bioluminescence, the peculiar ability of some organisms to behave like living night-lights. (this text was pblished in The Guardian)

  • Lynx1 protein competes with the amyloid peptide science news VII.4

    A joint study on the Lynx1 protein that was conducted by researchers from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences together with their colleagues from the universities of Copenhagen and Leipzig, has revealed that this protein competes with human nicotinic acetylcholine receptors for binding to amyloids, which are the main cause for the development of Alzheimer's disease. In the future, the protein could be used in the development of new treatment therapies or future combinations for the treatment of disease. The results of the experiment were published in the Neurobiology of Aging journal.